AMZN
Amazon.com, Inc.
AMZN has the edge over BWA overall, supported by stronger valuation and stronger modeled upside.
BWA
BorgWarner Inc.
BWA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BWA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Healthy |
BWA's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over BWA in the historical PE scenario, which offers more potential upside but is not a forecast.
BWA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.1x | $50.99 | — |
| Cheap | 11x | $25.48 | -50% |
| Fair | 13x | $31.93 | -37% |
| Current | 21x | $50.99 | — |
| Expensive | 30x | $71.22 | +40% |
Historical ranges are pointers, not guarantees.
BWA's PE is in its expensive range at 21x. If earnings grow as analysts expect, today's price would be 9.1x next year's earnings, in its cheap range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
BWA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect BWA's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BWA on earnings, with more consistent year-over-year improvement.
BWA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.60 | +135% |
| Q3 2026 | $2.38 | +240% |
| Q2 2026 | $2.03 | +101% |
| Q1 2026 | $1.72 | +30% |
| Q4 2025 | $1.28 | -15% |
| Q3 2025 | $0.70 | -82% |
| Q2 2025 | $1.01 | -68% |
| Q1 2025 | $1.32 | -50% |
| Q4 2024 | $1.50 | -44% |
BWA's earnings per share have fallen from their peak: $2.38 over the past year, against $4.08 in early 2023.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BWA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BWA on profitability, with a higher operating margin.
BWA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.5B | -2.9% |
| Q2 2026 | $3.6B | +0.3% |
| Q1 2026 | $3.5B | +0.5% |
| Q4 2025 | $3.6B | +3.9% |
| Q3 2025 | $3.6B | +4.1% |
| Q2 2025 | $3.6B | +1% |
| Q1 2025 | $3.5B | -2.2% |
| Q4 2024 | $3.4B | -2.4% |
BWA's revenue fell from its 2023 peak and has held roughly level since: $3.5B last quarter, down 2.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.7% | +1.8 points |
| Q2 2026 | 10% | +2.2 points |
| Q1 2026 | 9.5% | +2.8 points |
| Q4 2025 | -6.7% | +2.5 points |
| Q3 2025 | 6.9% | -0.9 points |
| Q2 2025 | 7.9% | -0.3 points |
| Q1 2025 | 6.7% | -1.5 points |
| Q4 2024 | -9.2% | -17 points |
BWA's operating margin was 8.7% last quarter, up 1.8 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BWA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $195M | -24% |
| Q2 2026 | $490M | -2.4% |
| Q1 2026 | $9M | +$46M |
| Q4 2025 | $457M | -12% |
| Q3 2025 | $257M | +28% |
| Q2 2025 | $502M | +69% |
| Q1 2025 | -$37M | +$271M |
| Q4 2024 | $521M | -23% |
BWA has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BWA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -1.7M shares |
| 1 year | -5.5% | -11.9M shares |
| 3 years | -13% | -30.7M shares |
| 5 years | -15% | -35.2M shares |
| Available history | -1.1% | -2.2M shares |
BWA has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $175M |
| Q2 2026 | $100M |
| Q1 2026 | $150M |
| Q4 2025 | $298M |
| Q3 2025 | $102M |
| Q2 2025 | $108M |
| Q1 2025 | — |
| Q4 2024 | $1M |
BWA spent $723M buying back its own shares over the past year, about three times what it spent the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over BWA on leverage, with a lower net debt burden relative to earnings.
BWA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.0x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q4 2024 | 1.7x | Healthy |
| Q3 2024 | 1.4x | Healthy |
| Q2 2024 | 1.4x | Healthy |
| Q1 2024 | 1.5x | Healthy |
| Q4 2023 | 1.2x | Healthy |
| Q3 2023 | 1.4x | Healthy |
BWA's net debt is about a year of its operating earnings (EBITDA), down from 1.4 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BWA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 8.4 | Oversold |
BWA's weekly RSI is 36 (neutral) and its Stochastic is 8 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BWA PE vs Consumer Cyclical Sector
| Metric | BWA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 71 | 47 | 24 pts above |
BWA has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BWA on trend strength, trading above more of its moving averages.
BWA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.0 | 8.9% below |
| 20 week MA | $61.7 | 17% below |
| 50 week MA | $58.3 | 13% below |
| 100 week MA | $46.8 | 8.9% above |
| 200 week MA | $41.9 | 22% above |
BWA has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 22% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BWA on returns for 2026, with the stronger performance.
BWA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.5 | $34.3 | -11% |
| 2021 | $34.3 | $38.4 | +12% |
| 2022 | $38.4 | $35.2 | -8.3% |
| 2023 | $35.2 | $35.9 | +1.9% |
| 2024 | $35.9 | $32.2 | -10% |
| 2025 | $32.2 | $45.6 | +42% |
| 2026 YTD | $45.6 | $51.0 | +12% |
BWA has finished lower in three of the last six years. It's up 12% so far in 2026.